Intravenous chemotherapy with cisplatin for regional lymph node metastases of auricular VX2 carcinoma.
BACKGROUND
The VX2 carcinoma is well established as a useful model for studies on treatment of primary tumors of various locations including the rabbit's auricle; however, limited experience exists on the treatment modalities of lymph node (LN) metastases. In this investigation we studied the frequency and extent of lymphogenic metastatic spread of auricular VX2-carcinomas and their response to systemic chemotherapy.


METHODS
Induction of a right-sided auricular VX2-carcinoma in 17 healthy New Zealand white rabbits was followed by ablation of the right auricle and intravenous application of 1 mg/kg KG CDDP (cisdiamminedichloroplatinum (II)) dissolved in 2 ml NaCl via the left-sided auricular vein in 10 rabbits (group 1), while 7 rabbits (group 2) remained untreated. After a 24-day follow-up period, animals of both groups were sacrificed and the regional draining LN as well as the lungs were isolated and examined histopathologically.


RESULTS
Group 1. Following intravenous cisplatin therapy (ICT), 6/10 animals showed no vital tumor cells within LN metastases of the first draining LN station, while 4/10 animals had necrotic LN metastases limited to the parotideal LN. Group 2. All 7 animals showed necrotic LN metastases of the first and second draining LN station as well as pulmonary metastases.


CONCLUSIONS
The auricular VX2-carcinoma, characterized by frequent lymphogenic metastatic spread and response of LN metastases to ICT, offers an excellent animal model for further studies on the optimised treatment of lymphogenic metastatic spread in HNSCC.
Dünne
A A
AA
Department of Otolaryngology, Head and Neck Surgery, Philipps-University of Marburg, Germany.
Kuropkat
C
C
Sapundzhiev
N
N
Ramaswamy
A
A
Sesterhenn
A
A
Schulz
S
S
Werner
J A
JA
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002945:Cisplatin / Q000494:pharmacology*; D004428:Ear Neoplasms / Q000188:drug therapy* / Q000473:pathology; D004431:Ear, External / Q000098:blood supply; D005260:Female; D007262:Infusions, Intravenous; D008207:Lymphatic Metastasis; D011817:Rabbits
D000970:Antineoplastic Agents; D002945:Cisplatin